Chemotherapy administration directly into the fourth ventricle in a new piglet model: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 1, Issue 5, 2008, Pages 373-380

  Sandberg, David I ^a,c   Crandall, Kenneth M ^a   Petito, Carol K ^a   Padgett, Kyle R ^a   Landrum, John ^b   Babino, Darwin ^b   He, Danshe ^a   Solano, Juan ^a   Gonzalez Brito, Manuel ^a   Kuluz, John W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Animal model; Chemotherapy; Fourth ventricle; Magnetic resonance imaging; Piglet; Posterior fossa tumor

Indexed keywords

ETOPOSIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FOURTH VENTRICLE; BRAIN STEM; CADAVER; CANCER CHEMOTHERAPY; CEREBELLUM; CHOROID PLEXITIS; CONTROLLED STUDY; CRANIECTOMY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG INDICATION; DRUG INFUSION; DRUG INSTILLATION; DRUG SAFETY; INDWELLING CATHETER; MENINGITIS; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PIGLET; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; CATHETERIZATION; CATHETERS, INDWELLING; ETOPOSIDE; FOURTH VENTRICLE; INFUSIONS, PARENTERAL; MODELS, ANIMAL; SWINE;

EID: 43449125911     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/PED/2008/1/5/373     Document Type: Article

References (26)

1. Balter-Seri J, Mor C, Shuper A, Zaizov R, Cohen IJ: Cure of recurrent medulloblastoma: the contribution of surgical resection at relapse. Cancer 79:1241-1247, 1997
2. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, et al: The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer 41:2431-2437, 1978
3. Chamberlain MC, Kormanik PA, Barba D: Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87:694-699, 1997
4. Choux M, Lena G, Alfonsi S, Bernard JL, Clément R, Elbaze F, et al: [Medulloblastoma.] Neurochirurgie 28 (1 Suppl):1-229, 1982 (Fr)
5. DeAngelis LM: Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 38:245-252, 1998
6. Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U: Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumors. Br J Cancer 84:1453-1459, 2001
7. Gajjar A, Kühl J, Epelman S, Bailey C, Allen J: Chemotherapy of medulloblastoma. Childs Nerv Syst 15:554-562, 1999
8. Gordon K, Dearmun AK: Occlusion problems in central venous catheters: the child and family perspective. J Child Health Care 7:55-69, 2003
9. Henwood JM, Brogden RN: Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Drugs 39:438-490, 1990
10. Jacobs A, Clifford P, Kay HE: The Ommaya reservoir in chemotherapy for malignant disease in the CNS. Clin Oncol 7:123-129, 1981
11. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J: Population-based epidemiologic data on brain tumors in German children. Cancer 92:3155-3164, 2001
12. Macdonald DR: Neurologic complications of chemotherapy. Neurol Clin 9:955-967, 1991
13. Obbens EA, Leavens ME, Beal JW, Lee YY: Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology 35:1274-1278, 1985
14. Petito CK, Adkins B: Choroid plexus selectively accumulates T-lymphocytes in normal controls and after peripheral immune activation. J Neuroimmunol 162:19-27, 2005
15. Reddy AT, Packer RJ: Medulloblastoma. Curr Opin Neurol 12:681-685, 1999
16. Reif S, Kingreen D, Kloft C, Grimm J, Siegert W, Schunack W, et al: Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients. Cancer Chemother Pharmacol 48:134-140, 2001
17. Rubinstein LJ, Herman MM, Long TF, Wilbur JR: Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35:291-305, 1975
18. Rutka JT: Medulloblastoma. Clin Neurosurg 44:571-585, 1997
19. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, et al: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986, 2005
20. Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH: Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47:49-55, 2000
21. Shapiro WR, Posner JB, Ushio Y, Chemik NL, Young DF: Treatment of meningeal neoplasms. Cancer Treat Rep 61:733-743, 1977
22. Silverman CL, Simpson JR: Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 8:1869-1876, 1982
23. Sirisangtragul C, Henke G, Fleischhack G, Reif S, Kloft C, Bode U, et al: Cerebrospinal fluid pharmacokinetics after different dosage regimens of intraventricular etoposide. Int J Clin Pharmacol Ther 41:606-607, 2003
24. Slavc I, Schuller E, Czech T, Hainfellner JA, Seidl R, Dieckmann K: Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination. J Neurooncol 38:213-218, 1998
25. Slavc I, Schuller E, Falger J, Günes M, Pillwein K, Czech T, et al: Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors. J Neurooncol 64:239-247, 2003
26. Suit HD, Westgate SJ: Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 12:453-458, 1986